Literature DB >> 30996380

[Comparison of the minimally invasive treatments of laparoscopic and endosopic for common bile duct stones after gastrojejunostomy].

L F Zhang1, C S Hou1, Y H Huang2, Z Xu1, L X Wang1, X F Ling1, G Wang1, L Cui1, D R Xiu1.   

Abstract

OBJECTIVE: To explore the feasibility and to compare the merits and demerits of laparoscopic and endoscopic approach in removing common bile duct stones in patients with gastrojejunostomy after gastrectomy.
METHODS: Between January 2012 and December 2016, 25 patients with common bile duct stones after gastrojejunostomy received laparoscopic or endoscopic treatment in our centers. They were divided into laparoscopic group and endoscopic group based on treatment approaches for common bile duct stones, including 15 patients in laparoscopic group and 10 in endoscopic group. The clinical characteristics and outcomes between the two groups were retrospectively analyzed.
RESULTS: Among the 25 patients with gastrojejunostomy, the method of reconstruction was Billroth II in 21 patients and Roux-en-Y in 4 patients. Six patients received laparoscopic or endoscopic treatment during the acute cholangitis state. Among the laparoscopic group, 5 patients with stones more than 1 cm, 7 patients with multiple stones, while in the endoscopic group, 3 patients with stones more than 1 cm and 4 patients with multiple stones. Fourteen patients in the laparoscopic group with coexisting gallbladder stones, and 6 of their common bile duct stones were successfully removed by transcystic approach without T tube drainage. Stone removals were successful in 4 patients of the endoscopic group by a single performance, including 3 patients with single small stone and one patient with multiple small stones. Two patients in the laparoscopic group were converted to open surgery for severe adhesion and one patient in the endoscopic group turned to laparoscopic operation for failing of finding papilla in the Roux-en-Y anastomotic status. The median hospital stays were 12 d and 10 d, respectively in the laparoscopic and endoscopic group. There were 3 patients with postoperative complications, including one patient with paralytic ileus in the laparoscopic group and 2 patients with biliary pancreatitis or bacteremia in the endoscopic group, and all of them recovered uneventfully with conservative treatment.
CONCLUSION: Both laparoscopic and endoscopic approaches are feasible for removing stones in the common bile duct in patients with gastrojejunostomy after gastrectomy, and they complement each other. In addition, both techniques are difficult to conduct, and a technical competence should be considered in selection of each method.

Entities:  

Mesh:

Year:  2019        PMID: 30996380      PMCID: PMC7441194     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  3 in total

1.  Adult colonoscopy or single-balloon enteroscopy-assisted ERCP in long-limb surgical bypass patients.

Authors:  Ke Li; Yong-Hui Huang; Wei Yao; Hong Chang; Xue-Biao Huang; Yao-Peng Zhang; Zhi-Qiang Song
Journal:  Clin Res Hepatol Gastroenterol       Date:  2014-02-20       Impact factor: 2.947

2.  Use of laparoscopic common bile duct exploration for failed endoscopic bile duct stone extractions.

Authors:  B Koc; G Adas; S Karahan
Journal:  Minerva Chir       Date:  2014-08       Impact factor: 1.000

3.  Treatment of biliary tract stones after gastrectomy in the era of laparoscopic cholecystectomy.

Authors:  Masaji Hashimoto; Tsunao Imamura; Tetsuo Tamura; Rikako Koyama; Yuko Koizumi; Mikio Makuuchi; Masamichi Matsuda; Goro Watanabe
Journal:  J Hepatobiliary Pancreat Sci       Date:  2016-09-19       Impact factor: 7.027

  3 in total
  1 in total

1.  Differences in Outcome and Comparison of Stress and Immune Status in Patients with Recurrent Common Bile Duct Stones after Biliary Tract Surgery Choosing Three Procedures (ERCP, OCBDE, and LCBDE) for Treatment.

Authors:  Dong Tan; Yafei Zhang
Journal:  Comput Math Methods Med       Date:  2022-01-05       Impact factor: 2.238

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.